Interview with Dr. Thomas Costa of Coventya
By Humatica
In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya (acquired by MacDermid Enthone in 2021), a leading international specialty chemicals company. Thomas has successfully led Coventya through 20 years of PE ownership before it was acquired by Element Solutions Inc (NYSE:ESI) this year.
Thomas speaks about his journey and the lessons learnt as a successful Private Equity CEO.
Listen to the podcast:
You can subscribe to the podcast on Spotify:
alpha Talks is the podcast dedicated to Private Equity value growth. Enno speaks to experienced buyout CEOs, operating partners, deal makers and advisors about their experience and lessons-learned in the industry.
Related Insights
Why 80% of AI Pilots Never Scale — and What the Successful 20% Do Differently
The AI pilot graveyard is large, and it is growing. Across the organisations we have worked with and the research we have reviewed, the pattern…
Read more
AI and Competitive Advantage: Why the Moat Is the Data, Not the Model
Every board strategy conversation about AI now includes a version of the same question: how do we use AI to get ahead, rather than just…
Read more
AI Risk: The 10 Things Every Board Should Know (and Most Don’t)
Corporate governance has always lagged behind the risks it is meant to manage. Boards develop oversight frameworks for risks after those risks have become embedded…
Read more
Subscribe to our Monthly Newsletter and other News Updates
Receive our news and valuable perspectives on organizational effectiveness each month.
